Literature DB >> 4774936

The determination of the acetylator phenotype of tuberculosis patients in Czechoslovakia using sulphadimidine.

A Víznerová, Z Slavíková, G A Ellard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4774936     DOI： 10.1016/0041-3879(73)90016-0

Source DB:  PubMed          Journal:  Tubercle        ISSN： 0041-3879


× No keyword cloud information.
  10 in total

1.  Acetylator status of kwashiorkor children in Ibadan (south-west Nigeria).

Authors:  L H Jeyakumar; U A Arowoshegbe; O O Akinyinka; F O Akinbami; E A Bababunmi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Jan-Mar       Impact factor: 2.441

2.  Pharmacokinetics of isoniazid metabolism in man.

Authors:  G A Ellard; P T Gammon
Journal:  J Pharmacokinet Biopharm       Date:  1976-04

Review 3.  Disease and acetylation polymorphism.

Authors:  P K Lunde; K Frislid; V Hansteen
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

4.  Human acetylator polymorphism: estimate of allele frequency in Libya and details of global distribution.

Authors:  A K Karim; M S Elfellah; D A Evans
Journal:  J Med Genet       Date:  1981-10       Impact factor: 6.318

Review 5.  Survey of the human acetylator polymorphism in spontaneous disorders.

Authors:  D A Evans
Journal:  J Med Genet       Date:  1984-08       Impact factor: 6.318

6.  Acetylation polymorphism and leprosy.

Authors:  L C Eze; A N Okpogba; A U Ogan
Journal:  Biochem Genet       Date:  1990-02       Impact factor: 1.890

7.  Acetylator polymorphism in rheumatoid arthritis.

Authors:  J M Ladero; M P Andres; A Bañares; B Fernández; C Hernández; J Benítez
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  The association of the slow acetylator phenotype with bladder cancer.

Authors:  D A Evans; L C Eze; E J Whibley
Journal:  J Med Genet       Date:  1983-10       Impact factor: 6.318

Review 9.  Clinical pharmacokinetics of isoniazid.

Authors:  W W Weber; D W Hein
Journal:  Clin Pharmacokinet       Date:  1979 Nov-Dec       Impact factor: 6.447

10.  Acetylator phenotyping of tuberculosis patients using matrix isoniazid or sulphadimidine and its prognostic significance for treatment with several intermittent isoniazid-containing regimens.

Authors:  G A Ellard; P T Gammon
Journal:  Br J Clin Pharmacol       Date:  1977-02       Impact factor: 4.335
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.